Extract

To evaluate the efficacy of ProLindac combined with paclitaxel in patients with advanced epithelial ovarian cancer, previously treated with cisplatin or carboplatin, who are potentially platinum-sensitive (platinum-free, progression-free interval 12 months)

Inclusion criteria

• Advanced Ovarian Cancer

Links

• euctr
• ictrp